Amid the ongoing Covid-19 vaccination drive, the Union government has placed an order for 66 crore doses of Serum Institute of India's (SII) Covishield and Bharat Biotech's Covaxin.
The order has been placed for supply of 66 crore Covid-19 vaccine doses at a cost of Rs 14,505.75 crore between August and December.
Further, 22 crore Covid-19 vaccine doses will be made available to the private sector.
Over the next five months, the government aims to get 37.5 crore doses of Covishield and 28.5 crore of Bharat Biotech's Covaxin, reports Economic Times.
The fresh order has been placed at Rs 215.25 per dose for Covishield and Rs 225.75 per dose for Covaxin, inclusive of GST.
The development comes as Centre, in an affidavit filed on 25 June, told the Supreme Court that India will have access to 1.35 Covid-19 vaccine doses through December, enough to cover the eligible adult population of the country.
The government's estimate includes 50 crore doses of Covishield, 40 crore of Covaxin, 30 crore of Biological E's vaccine, 5 crore of Zydus' jab and 10 crore Russian Sputnik V jabs.
An appeal from Swarajya
At Swarajya, we rely on our readers' support through subscriptions to sustain our media platform. Unlike larger conglomerates, we are unable to relentlessly chase advertising money — our model is largely built on your patronage.
Your support has never been more crucial. We work tirelessly to deliver 10-15 high-quality articles daily, ensuring you receive insightful content from 7 AM to 10 PM.
If you believe India's story has to be articulated in a way it has never been done before without shrugging it off, become a patron (or) subscribe now for ₹̶2̶4̶0̶0̶ ₹1999 and get 12 print issues, unlimited digital access for 1 year, a special India that is Bharat T-shirt (Offer ends soon).
We are counting on you!